Aug 7 (Reuters)-
Immuno Biological Laboratories Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Jun 30, 2020 Jun 30, 2019 Mar 31, 2021
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 116 mln 113 mln 549 mln
(+2.9 pct) (-34.0 pct) (-4.8 pct)
Operating loss 101 mln loss 104 mln loss 308 mln
Recurring loss 127 mln loss 127 mln loss 410 mln
Net loss 129 mln loss 124 mln loss 430 mln
EPS loss 13.85 yen loss 14.28 yen loss 46.16 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Immuno Biological Laboratories Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T